Pasithea Therapeutics Corp. - Common Stock (KTTA)

Historical Holders from Q1 2024 to Q3 2025

Symbol
KTTA on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
102M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
612K
Holdings value
$441K
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
18
Number of buys
12
Number of sells
-5
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Pasithea Therapeutics Corp. - Common Stock (KTTA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Vivo Opportunity Fund Holdings, L.P. 9.99% $12.3M 17.6M Vivo Opportunity Fund Holdings, L.P. 01 Dec 2025
JANUS HENDERSON GROUP PLC 9.99% $7.16M 10.2M JANUS HENDERSON GROUP PLC 28 Nov 2025
Squadron Capital Management LLC 9.9% $1.58M 2.25M Squadron Capital Management LLC 28 Nov 2025
CVI Investments, Inc. 9.9% 0% $570K $137K 826K +31.7% CVI Investments, Inc. 30 Jun 2025
Orca Capital AG 4.9% -13.3% $613K -$14K 363K -2.23% Orca Capital AG 07 May 2025
INTRACOASTAL CAPITAL, LLC 4.99% $537K 318K Mitchell P. Kopin 06 May 2025
ARMISTICE CAPITAL, LLC 4.99% -50% $240K $14K 142K +6.2% Armistice Capital, LLC 31 Mar 2025
STEINMAN LAWRENCE 3.1% $142K 83.9K Lawrence Steinman 01 Mar 2025

Institutional Holders of Pasithea Therapeutics Corp. - Common Stock (KTTA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 612K $441K +$225K $0.73 18
2025 Q2 300K $217K +$152K $0.72 10
2025 Q1 78.7K $99.1K -$117K $1.30 7
2024 Q4 77.2K $243K +$214K $3.15 7
2024 Q3 9.09K $48.9K -$103K $5.42 6
2024 Q2 30K $152K -$300 $5.06 7
2024 Q1 30.1K $218K +$218K $7.28 6